HLA-identical sibling bone marrow transplants vs chemotherapy for acute myelogenous leukemia in first remission

Leukemia

Volumn 10, Issue 11, 1996, Pages 1687-1691

  Gale, R P ^a   Buchner T ^b   Zhang, M J ^c   Heinecke, A ^b   Champlin, R E ^d   Dicke, K A ^e   Gluckman, E ^f   Good, R A ^g   Gratwohl, A ^h   Herzig, R H ⁱ   Keating, A ^j   Klein, J P ^c   Marmont, A M ^k   Prentice, H G ^l   Rowlings, P A ^c   Sobocinski, K A ^c   Speck, B ^h   Weiner, R S ^m   Horowitz, M M ^c  

^a Salick Health Care Inc   (United States)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e Arlington Cancer Center   (United States)

^f SAINT LOUIS HOSPITAL   (France)

^g JOHNS HOPKINS ALL CHILDREN S HOSPITAL   (United States)

^h UNIVERSITY HOSPITAL BASEL   (Switzerland)

ⁱ JEWISH HOSPITAL   (United States)

^j UNIVERSITY HEALTH NETWORK   (Canada)

^k UNIVERSITY OF GENOA   (Italy)

^l ROYAL FREE HOSPITAL   (United Kingdom)

^m TULANE UNIVERSITY MEDICAL CENTER   (United States)

more..

Author keywords

Acute myelogenous leukemia; Bone marrow transplantation; Chemotherapy

Indexed keywords

CYTARABINE; DAUNORUBICIN; METHOTREXATE; MITOXANTRONE; TIOGUANINE;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; BONE MARROW; BONE MARROW TRANSPLANTATION; CHEMOTHERAPY; CHROMOSOME ABERRATION; HLA TYPING; HUMAN; LEUKEMIA REMISSION; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 10344225040     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Mayer RJ. Allogeneic transplantation versus intensive chemotherapy in first-remission acute leukemia: is there a 'best choice'? J Clin Oncol 1988; 6: 1532-1536.
2. Keating A, Gale RP. Evaluating therapy of AML. In: Gale RP (ed). Acute Myelogenous Leukemia: Progress and Controversies. Alan R Liss: New York, 1990, pp 163-164.
3. Lowenberg B. Post-remission treatment of acute myelogenous leukemia. New Engl J Med 1995; 332: 260-262.
4. Büchner T. Acute leukemia. Curr Opin Hematol 1993; 1: 172-182.
5. Rowlings PA, Passweg JR, Armitage JO, Gale RP, Sobocinski KA, Klein JP, Zhang MJ, Horowitz MM. Report from the International Bone Marrow Transplant Registry and the Autologous Blood and Marrow Transplant Registry - North America. In: Terasaki PI, Cecka JM (eds). Clinical Transplants 1994. UCLA Tissue Typing Laboratory: Los Angeles, 1995, pp 87-98.
6. Büchner T, Hiddemann W, Löffler G, Gassmann W, Maschmeyer G, Heit W, Hossfeld D, Weh H, Ludwig W-D, Thiel E, Nowrousian M, Aul C, Lengfelder E, Lathan B, Mainzer K, Urbanitz D, Emmerich B, Middelhoff G, Donhuijsen-Ant HR, Hellriegel H-P, Heinecke A. Improved cure rate by very early intensification combined with prolonged maintenance chemotherapy in patients with acute myeloid leukemia: data from the AML Cooperative Group. Semin Hematol 1991; 28 (Suppl. 4): 76-79.
7. Anderson PK, Borgan O, Gill RD, Keiding N. Statistical Models Based on Counting Processes. Springer: New York, 1993.
8. Woodroofe M. Estimating a distribution function with truncated data. Ann Stats 1985; 13: 163-177.
9. Klein JP, Zhang MJ. Statistical challenges in comparing chemotherapy and bone marrow transplantation as a treatment for leukemia. In: Jewell NP (ed). Lifetime Data: Models in Reliability and Survival Analysis. Kluwer: The Netherlands, 1996, pp 175-185.
10. Andersen PK, Bentzon R, Klein JP. Estimating the survival function in the proportional hazards regression model: a study of small sample size properties. Scand J Stat 1996; 23: 1-12.
11. Appelbaum FR, Fisher LD, Thomas ED. Chemotherapy v. marrow transplantation for adults with acute nonlymphocytic leukemia: a five-year follow-up. Blood 1988; 72: 179-184.
12. Begg CB, McGlave PB, Bennett JM, Cassileth PA, Oken MM. A critical comparison of allogeneic bone marrow transplantation and conventional chemotherapy as treatment for acute nonlymphocytic leukemia. J Clin Oncol 1984; 2: 369-378.
13. Champlin RD, Ho WG, Gale RP, Winston D, Selch M, Mitsuyasu R, Lenarsky C, Elashoff R, Zighelboim J, Feig SA. Treatment of acute myelogenous leukemia: a prospective controlled trial of bone marrow transplantation versus consolidation chemotherapy. Ann Intern Med 1985; 102: 285-291.
14. Conde E, Iriondo A, Rayon C, Richard C, Fanjul E, Garijo J, Hermosa V, Coma A, Bello C, Carrera D, Baro J, Zubizarreta A. Allogeneic bone marrow transplantation versus intensification chemotherapy for acute myelogeneous leukaemia in first remission: a prospective controlled trial. Br J Haematol 1988; 68: 219-226.
15. Ferrant A, Doyen C, Delannoy A, Cornu G, Martiat D, Latinne D, De Bruyère M, Bosly A, Michaux JL, Sokal G. Allogeneic or autologous bone marrow transplantation for acute non-lymphocytic leukemia in first remission. Bone Marrow Transplant 1991; 7: 303-309.
16. Gorin NC, Aegerter P, Auvert B, Meloni G, Goldstone AH, Burnett A, Carella A, Korbling M, Herve P, Maraninchi D, Löwenberg R, Verdonck LF, de Planque M, Hermans J, Helbig W, Porcellini A, Rizzoli V, Alesandrino EP, Franklin IM, Reiffers J, Colleselli P, Goldman JM. Autologous bone marrow transplantation for acute myelocytic leukemia in first remission: a European survey of the role of marrow purging. Blood 1990; 75: 1606-1614.
17. Zander AR, Keating M, Dicke K, Dixon D, Pierce S, Jagannath S, Peters L, Horwitz L, Cockerill K, Spitzer G et al. A comparison of marrow transplantation with chemotherapy for adults with acute leukemia of poor prognosis in first complete remission. J Clin Oncol 1988; 6: 1548-1557.
18. Gale RP, Horowitz MM, Biggs JC, Herzig RH, Kersey JH, Marmont AM, Masaoka T, Rimm AA, Speck B, Weiner RS, Zwaan FE, Bortin MM for the Advisory Committee of the International Bone Marrow Transplant Registry. Transplant or chemotherapy in acute myelogenous leukaemia. Lancet 1989; 1: 1119-1122.
19. Reiffers J, Gaspard MH, Maraninchi D, Michallet M, Marit G, Stoppa AM, Corront B, David B, Gastaut JA, Sotto JJ, Broustet A, Carcassone Y, Hollard D. Comparison of allogeneic or autologous bone marrow transplantation and chemotherapy in patients with acute myeloid leukemia in first remission: a prospective controlled trial. Br J Haematol 1989; 72: 57-63.
20. Schiller GJ, Nimer SD, Territo MC, Ho WG, Champlin RE, Gajewski JL. Bone marrow transplantation versus high-dose cytarabine-based combination chemotherapy for acute myelogenous leukemia in first remission. J Clin Oncol 1992; 10: 41-46.
21. Willemze R, Fibbe WE, Kluin-Nelemans JC, Falkenburg JH, Richel DJ, Peters WG, den Ottolander GJ, Brand A, Zwaan FE. Bone marrow transplantation or chemotherapy as post-remission treatment of adult acute myelogenous leukemia. Ann Hematol 1991; 62: 59-63.
22. Hermans J Suciu S, Stijnen T, Aegerter P, Gorin NC, Gratwohl A, Hayat M, Stryckmans P, Zittoun R, Fwaan FE. Treatment of acute myelogenous leukemia: an EBMT-EORTC retrospective analysis of chemotherapy versus allogeneic or autologous bone marrow transplantation. Eur J Cancer Clin Oncol 1989; 25: 545-550.
23. Ljungman P, de Witte T, Verdonck L, Gahrton G, Freycon F, Graven P, McCann S, Morgenstern HG, Nikoskelainen J, Powles R, Proctor SJ, Volin L, Zwaan F, Gratwohl A, Bone marrow transplantation for acute myeloblastic leukaemia. An EBMT Leukaemia Working Party proespective analysis from HLA-typing. Br J Haematol 1993; 84: 61-66.
24. Zittoun RA, Mandelli F, Willemze R, de Witte T, Labar B, Resegotti L, Leoni F, Damasio E, Visani G, Papa G, Caronia F, Hayat M, Stryckmans P, Rotoli B, Leoni P, Peetermans M, Dardenne M, Vegna M, Petti M, Solbu G, Suciu S. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. New Engl J Med 1995; 332: 217-223.
25. Burnett AK, Goldstone AH, Stevens RF, Hann IM, Rees JK, Wheatley K, Gray RG. The role of bone marrow transplantation in addition to intensive chemotherapy in AML in first CR: results of the MRC AML-10 trial. Blood 1994; 84 (Suppl. 1): 252a (Abstr. 992).
26. Harousseau JL, Pignon B, Witz F, Linassier P, Lioure B, Le Prise PY, Cahn JY, Desablens B, Caillot D, Ifrah N, Abgrall JF, Sadoun A, Guyotat D, Mors A, Casassus P, Brière J, Polin V, Berthaud P, Hurteloup P. Prospective comparison of allogeneic bone marrow transplantation, intensive consolidation chemotherapy and unpurged autologous bone marrow transplantation as post remission therapy in adult acute myeloid leukemia. Blood 1994; 84: 251a (Abstr. 991).
27. Arthur DC, Berger R, Golumb HM, Swansbury GJ, Reeves BR, Alimena G, Van Den Berghe H, Bloomfield CD, de la Chapelle A, Dewald GW et al. The clinical significance of karyotype in acute myelogenous leukemia. Cancer Genet Cytogenet 1989; 40: 203-216.
28. Keating MJ, Smith TL, Kantarjian H, Cork A, Walters R, Trujillo JM, McCredie KB, Gehan EA, Freireich EJ. Cytogenetic pattern in acute myelogenous leukemia: a major reproducible determinant of outcome. Leukemia 1988; 2: 403-412.
29. Gale RP, Horowitz MM, Weiner RS, Ash RC, Atkinson KM, Babu R, Dicke KA, Klein JP, Lowenberg B, Reiffers J, Rimm AA, Rowlings PA, Sandberg AA, Sobocinski KA, Veum-Stone J, Bortin MM. Impact of cytogenetic abnormalities on outcome of bone marrow transplants in acute myelogenous leukemia in first remission. Bone Marrow Transplant 1995; 16: 203-208.
30. Wolff SN, Herzig RH, Fay JW, Phillips GL, Lazarus HM, Flexner JM, Stein RS, Greer JP, Cooper B, Herzig GP. High-dose cytarabine and daunorubicin as consolidation therapy for acute myeloid leukemia in first remission: long-term follow-up and results. J Clin Oncol 1989; 7: 1260-1267.
31. Mayer RJ, Davis RB, Schiffer CA, Berg DT, Powell BL, Schulman P, Omura GA, Moore JO, McIntyre OR, Frei E III. Intensive postremission chemotherapy in adults with acute myeloid leukemia. New Engl J Med 1994; 331: 896-903.
32. Bortin MM, Horowitz MM, Gale RP, Barrett AJ, Champlin RE, Dicke KA, Gluckman E, Kolb H-J, Marmont AM, Mrsic M, Sobocinski KA, Weiner RS, Rimm AA. Changing trends in allogeneic bone marrow transplantation for leukemia in the 1980s. JAMA 1992; 268: 607-612.
33. Gale RP, Horowitz MM, Rees JKH, Gray RG, Oken MM, Estey EH, Kim KM, Zhang M-J, Ash RC, Atkinson K, Champlin RE, Dicke KA, Gajewski JL, Goldman JM, Helbig W, Henslee-Downey PJ, Hinterberger W, Jacobsen N, Keating A, Klein JP, Marmont AM, Prentice HC, Reiffers J, Rimm AA, Rowlings PA, Sobocinski KA, Speck B, Wingard JR, Bortin MM. Chemotherapy versus transplants for acute myelogenous leukemia in second remission. Leukemia 1996; 10: 13-19.
34. Appelbaum FR, Clift RA, Buckner CD, Stewart P, Storb R, Sullivan KM, Thomas ED. Allogeneic marrow transplantation for acute nonlymphoblastic leukemia after first relapse. Blood 1983; 61: 949-953.
35. Clift RA, Buckner CD, Appelbaum FR, Schoch G, Petersen FB, Bensinger WI, Sanders I, Sullivan KM, Storb R, Singer J, Hansen JA, Thomas ED. Allogeneic marrow transplantation during untreated first relapse of acute myeloid leukemia. J Clin Oncol 1992; 10: 1723-1729.